Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -50.77% is in line with its 5-year average of -51.13%, near the high end of its 5-year range (-1483.25%–-10.48%).
As of the fiscal period ended Tuesday, June 30, 2026. 15.30% above its 12-month average of -59.94%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -50.77%.
RETURN ON INVESTED CAPITAL (ROIC)
-50.77%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-59.94%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-34.39%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-51.13%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+15.30%
CURRENT VS 3Y AVG
-47.63%
CURRENT VS 5Y AVG
+0.71%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-34.77%
median of 761 covered companies
CURRENT VS SECTOR MEDIAN
-46.01%
vs the sector median at left
MoonLake Immunotherapeutics
Market Cap
$938.92M
Return on Invested Capital (ROIC)
-50.77%
TTM Avg
-59.94%
3Y Avg
-34.39%
5Y Avg
-51.13%
Market Cap
$931.25M
Return on Invested Capital (ROIC)
-46.54%
TTM Avg
-25.88%
3Y Avg
-39.60%
5Y Avg
-39.60%
Market Cap
$950.77M
Return on Invested Capital (ROIC)
-67.13%
TTM Avg
-38.55%
3Y Avg
-37.38%
5Y Avg
-31.65%
Market Cap
$950.17M
Return on Invested Capital (ROIC)
-36.95%
TTM Avg
-36.95%
3Y Avg
-36.95%
5Y Avg
-36.95%
Market Cap
$952.91M
Return on Invested Capital (ROIC)
-82.30%
TTM Avg
-52.55%
3Y Avg
-42.51%
5Y Avg
-41.57%
Market Cap
$919.80M
Return on Invested Capital (ROIC)
-66.23%
TTM Avg
-66.23%
3Y Avg
-66.23%
5Y Avg
-66.23%
Market Cap
$915.21M
Return on Invested Capital (ROIC)
4.96%
TTM Avg
4.19%
3Y Avg
3.59%
5Y Avg
3.20%
Market Cap
$966.65M
Return on Invested Capital (ROIC)
-16.54%
TTM Avg
-24.45%
3Y Avg
-23.43%
5Y Avg
-23.43%
Market Cap
$898.03M
Return on Invested Capital (ROIC)
11.37%
TTM Avg
4.29%
3Y Avg
-4.73%
5Y Avg
-2.12%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | $938.92M | -50.77% | -59.94% | -34.39% | -51.13% |
| CeriBell, Inc. (CBLL)vs › | $931.25M | -46.54% | -25.88% | -39.60% | -39.60% |
| Kura Oncology, Inc. (KURA)vs › | $950.77M | -67.13% | -38.55% | -37.38% | -31.65% |
| Seaport Therapeutics, Inc. Common Stock (SPTX)vs › | $950.17M | -36.95% | -36.95% | -36.95% | -36.95% |
| Savara Inc. (SVRA)vs › | $952.91M | -82.30% | -52.55% | -42.51% | -41.57% |
| Odyssey Therapeutics, Inc. (ODTX)vs › | $919.80M | -66.23% | -66.23% | -66.23% | -66.23% |
| HealthStream, Inc. (HSTM)vs › | $915.21M | 4.96% | 4.19% | 3.59% | 3.20% |
| Aktis Oncology, Inc. (AKTS)vs › | $966.65M | -16.54% | -24.45% | -23.43% | -23.43% |
| Bioventus Inc. (BVS)vs › | $898.03M | 11.37% | 4.29% | -4.73% | -2.12% |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $979.53M | -28.14% | -132.46% | -76.17% | -76.17% |
ROIC
-50.8%
ROE
-61.6%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -50.77% |
| 2026-03-31 | -75.47% |
| 2025-12-31 | -64.40% |
| 2025-09-30 | -62.63% |
| 2025-06-30 | -46.42% |
| 2025-03-31 | -35.04% |
| 2024-12-31 | -31.42% |
| 2024-09-30 | -21.79% |
| 2024-06-30 | -14.72% |
| 2024-03-31 | -10.99% |
| 2023-12-31 | -10.48% |
| 2023-09-30 | -11.39% |
| 2023-06-30 | -11.53% |
| 2023-03-31 | -104.26% |
| 2022-12-31 | -94.05% |
| 2022-09-30 | -75.86% |
| 2022-06-30 | -57.24% |
| 2022-03-31 | -158.75% |
| 2021-12-31 | -1483.25% |
| 2021-09-30 | -34.28% |
